135 related articles for article (PubMed ID: 7515330)
1. Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1.
Gregorian SK; Lee WP; Beck LS; Rostami A; Amento EP
Cell Immunol; 1994 Jun; 156(1):102-12. PubMed ID: 7515330
[TBL] [Abstract][Full Text] [Related]
2. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
Gregorian SK; Rostami A
J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
[TBL] [Abstract][Full Text] [Related]
5. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
[TBL] [Abstract][Full Text] [Related]
6. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis.
Kiefer R; Gold R; Gehrmann J; Lindholm D; Wekerle H; Kreutzberg GW
J Neurosci Res; 1993 Nov; 36(4):391-8. PubMed ID: 7505838
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
[TBL] [Abstract][Full Text] [Related]
11. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
[TBL] [Abstract][Full Text] [Related]
12. A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
Yun W; Hua-bing W; Wei-zhi W
J Neuroimmunol; 2007 Apr; 185(1-2):87-94. PubMed ID: 17346805
[TBL] [Abstract][Full Text] [Related]
13. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
[TBL] [Abstract][Full Text] [Related]
14. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
Araga S; Kishimoto M; Doi S; Nakashima K
J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
[TBL] [Abstract][Full Text] [Related]
15. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats.
Izumo S; Linington C; Wekerle H; Meyermann R
Lab Invest; 1985 Aug; 53(2):209-18. PubMed ID: 2410663
[TBL] [Abstract][Full Text] [Related]
16. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
Malotky MK; Pope L; Miller SD
J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
[TBL] [Abstract][Full Text] [Related]
17. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
[TBL] [Abstract][Full Text] [Related]
18. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Nennesmo I; Adem A; Zhu J
Exp Neurol; 2004 Dec; 190(2):486-94. PubMed ID: 15530887
[TBL] [Abstract][Full Text] [Related]
19. Effect of stilbene-type anion channel blockers on the immune response during experimental allergic neuritis (EAN).
Mix E; Correale J; Olsson T; Solders G; Link H
Immunopharmacol Immunotoxicol; 1992; 14(3):579-609. PubMed ID: 1381387
[TBL] [Abstract][Full Text] [Related]
20. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.
Linington C; Izumo S; Suzuki M; Uyemura K; Meyermann R; Wekerle H
J Immunol; 1984 Oct; 133(4):1946-50. PubMed ID: 6206142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
